Dr. Zheng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University of Kansas Medical Center
3901 Rainbow Blvd
Kansas City, KS 66160Phone+1 913-588-7071Fax+1 913-588-7073
Summary
- I am a board certified pathologist, specialized in laboratory medicine, transfusion medicine, and coagulation. My laboratory focuses on understanding the molecular mechanism of thrombotic thrombocytopenic purpura (TTP) and atypical hemolytic uremic syndrome (HUS) and developing novel diagnostic and therapeutic tools for these rare but potentially fatal disorders.
Education & Training
- Washington University/B-JH/SLCH ConsortiumFellowship, Blood Banking/Transfusion Medicine, 2002 - 2003
- Washington University/B-JH/SLCH ConsortiumResidency, Pathology-Anatomic and Clinical, 1999 - 2002
- University of ViennaPh.D., Mol. Cell. Biology, 1991 - 1994
- Tongji Medical College, Huazhong University of Science and TechnologyMSc, Obs/Gyn, 1987
- Medical College of Nanchang UniversityClass of 1984, M.D.
Certifications & Licensure
- Alabama Sate Medical License, AL 2014 - Present
- KS State Medical License 2020 - 2025
- PA State Medical License 2003 - 2024
- NJ State Medical License 2008 - 2021
- American Board of Pathology Clinical Pathology
- American Board of Pathology Blood Banking/Transfusion Medicine
Awards, Honors, & Recognition
- Distinguished pathologist award Chinese American Pathologists Association, 2024
- Gift-of-Life Award RayWinn Foundation, NJ, 2014
- Karl-Link New Investigator Award for Hemostasis ATVB, American Heart Association, 2012
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsADAMTS13 or Caplacizumab Reduces the Accumulation of Neutrophil Extracellular Traps and Thrombus in Whole Blood of COVID-19 Patients under Flow.Noritaka Yada, Quan Zhang, Antonia Bignotti, Zhan Ye, X Long Zheng
Thrombosis and Haemostasis. 2024-08-01 - 2 citationsTargeting neutrophil extracellular trap accumulation under flow in patients with immune-mediated thrombotic thrombocytopenic purpura.Noritaka Yada, Quan Zhang, Antonia Bignotti, Sarah H Gralnek, Dennis Sosnovske
Blood Advances. 2024-05-28 - 1 citationsMechanism underlying severe deficiency of plasma ADAMTS-13 activity in immune thrombotic thrombocytopenic purpura.X Long Zheng
Journal of Thrombosis and Haemostasis. 2024-05-01
Journal Articles
- Understanding thrombotic microangiopathies in childrenJoly BS, Zheng XL and Veyradier A, Inten Care Med, 1/24/2018
- Low Plasma ADAMTS13 Activity is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Pediatric TraumaRussell RT, McDaniel JK, Cao WJ, Shroyer M, Wagener BM, Zheng XL (corr. au.), JF Pittet, Thromb Haemost, 1/1/2018
- Mutations in Coagulation Factor VIII Are Associated with More Favorable Outcome in Patients with Cutaneous MelanomaPing Z., Soni A., Williams AL, Pham HP, Basu MK, and Zheng XL, TH Open, 1/1/2017
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- African American Race Is Associated with Decreased Relapse-Free Survival in Immune Thrombotic Thrombocytopenic PurpuraX. Long Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Plasma Levels of Histone-DNA Complex and Cell-Free DNA Predict Mortality in Patients with Immune Thrombotic Thrombocytopenic PurpuraX. Long Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Longitudinal Assessment of Plasma ADAMTS13 Biomarkers Helps Predict Recurrence of Immune Thrombotic Thrombocytopenic PurpuraX. Long Zheng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- A journey from Obstetrician to pathologist1/1/2018
- TMA: from zebrafish to men1/1/2018
- HUS: Dual Presentation Diagnosis and TreatmentWestchester Medical Center, Valhalla, NY - 1/1/2018
- Join now to see all
Grant Support
- Novel Therapeutics for Thrombotic Thrombocytopenic PurpuraNHLBI2019–2024
- Zebrafish model of Thrombotic Thrombocytopenic PurpuraAmerican Heart Association (Mentor)2019–2020
- Complement activation in pathogenesis of TTPAnswering T.T.P. Foundation2015–2020
- Pathogenesis of Thrombotic MicroangiopathyNHLBI2015–2020
- Structure and function of ADAMTS13NHLBI2005–2010
- Cofactor-dependent regulation of VWF proteolysisNHLBI2005–2010
Committees
- Member, ISTH 2024 symposium planning 2023 - Present
- Co-chair, ISTH SSC 2022 - Present
- Member, NIH HTBT study section 2018 - Present
Research History
- Professor at University of Alabama at Birmingham, Birmingham, AL2015 - 2020
- Associate Professor at University of Pennsylvania, Philadelphia, PA2011 - 2015
- Assistant Professor at University of Pennsylvania, Philadelphia, PA2003 - 2011
- Postdoctoral fellow, Washington University in St. Louis, MO1995 - 1999
Professional Memberships
- Member
- Member
- Member
- Academy of Laboratory Physicians and ScieintistsMember
- International Society of Thrombosis and HaemostasisMember
- American Association of Blood Bank and Cellular TherapyMember
- Association of Pathology ChairsMember
Other Languages
- Chinese (Mandarin), German
Industry Relationships
- Consultant, Sanofi2020 - Present
- Consultant, Takeda2019 - Present
- Co-founder, Clotsolution2018 - Present
- Speaker, Sanofi-Genzyme2019 - 2020
- Speaker, Alexion2012 - 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: